Plasma exchange: An efective rescue therapy in critically ill patients with coronavirus disease 2019 infection

Resumen

Objectives: Infection by severe acute respiratory syndrome coronavirus-2 can induce uncontrolled systemic inflammation and multiple organ failure. The aim of this study was to evaluate if plasma exchange, through the removal of circulating mediators, can be used as rescue therapy in these patients. Design: Single center case series. Setting: Local study. Subjects: Four critically ill adults with coronavirus disease 19 pneumonia that failed conventional interventions. Interventions: Plasma exchange. Two to six sessions (1.2 plasma volumes). Human albumin (5%) was used as the main replacement fluid. Fresh frozen plasma and immunoglobulins were administered after each session to avoid coagulopathy and hypogammaglobulinemia. Measurements and main results: Serum markers of inflammation and macrophage activation. All patients showed a dramatic reduction in inflammatory markers, including the main cytokines, and improved severity scores after plasma exchange. All survived to ICU admission. Conclusions: Plasma exchange mitigates cytokine storm, reverses organ failure, and could improve survival in critically ill patients with coronavirus disease 2019 infection.

Tipo de documento

Artículo


Versión publicada

Lengua

Inglés

Materias y palabras clave

COVID-19; Plasma sanguini; COVID-19; Blood plasma

Publicado por

Lippincott, Williams & Wilkins

Documentos relacionados

Reproducció del document publicat a: https://doi.org/10.1097/CCM.0000000000004613

Critical Care Medicine, 2020, vol. 48, num. 12, p. e1350-e1355

https://doi.org/10.1097/CCM.0000000000004613

Citación recomendada

Esta citación se ha generado automáticamente.

Derechos

cc-by-nc-nd (c) Fernández et al., 2020

http://creativecommons.org/licenses/by-nc-nd/3.0/es